The move caps a rapid rise for Thomas Schinecker, who joined Roche's management development programme in 2003, and was previously head of the company's diagnostics division. The changes, effective after Roche's annual general meeting on March 14, 2023, see the end of Schwan's 14-year tenure as CEO.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/TtA6wWX
0 Comments